155 related articles for article (PubMed ID: 33022214)
1. Introduction of a de novo Creb-binding protein gene mutation in sperm to produce a Rubinstein-Taybi syndrome model using inbred C57BL/6 mice.
Takagi T; Higashi Y; Asai M; Ishii S
Brain Res; 2020 Dec; 1749():147140. PubMed ID: 33022214
[TBL] [Abstract][Full Text] [Related]
2. Rubinstein-Taybi Syndrome and Epigenetic Alterations.
Korzus E
Adv Exp Med Biol; 2017; 978():39-62. PubMed ID: 28523540
[TBL] [Abstract][Full Text] [Related]
3. Administration of BMP2/7 in utero partially reverses Rubinstein-Taybi syndrome-like skeletal defects induced by Pdk1 or Cbp mutations in mice.
Shim JH; Greenblatt MB; Singh A; Brady N; Hu D; Drapp R; Ogawa W; Kasuga M; Noda T; Yang SH; Lee SK; Rebel VI; Glimcher LH
J Clin Invest; 2012 Jan; 122(1):91-106. PubMed ID: 22133875
[TBL] [Abstract][Full Text] [Related]
4. Mutation of the CH1 Domain in the Histone Acetyltransferase CREBBP Results in Autism-Relevant Behaviors in Mice.
Zheng F; Kasper LH; Bedford DC; Lerach S; Teubner BJ; Brindle PK
PLoS One; 2016; 11(1):e0146366. PubMed ID: 26730956
[TBL] [Abstract][Full Text] [Related]
5. Syndromic features and mild cognitive impairment in mice with genetic reduction on p300 activity: Differential contribution of p300 and CBP to Rubinstein-Taybi syndrome etiology.
Viosca J; Lopez-Atalaya JP; Olivares R; Eckner R; Barco A
Neurobiol Dis; 2010 Jan; 37(1):186-94. PubMed ID: 19822209
[TBL] [Abstract][Full Text] [Related]
6. CREBBP gene mutation in an infant with Rubinstein-Taybi syndrome.
Shen J; Zhao M; Zeng Z; He W; Chen C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Feb; 45(2):198-203. PubMed ID: 32386048
[TBL] [Abstract][Full Text] [Related]
7. Rubinstein-Taybi syndrome type 2: report of nine new cases that extend the phenotypic and genotypic spectrum.
Hamilton MJ; Newbury-Ecob R; Holder-Espinasse M; Yau S; Lillis S; Hurst JA; Clement E; Reardon W; Joss S; Hobson E; Blyth M; Al-Shehhi M; Lynch SA; Suri M;
Clin Dysmorphol; 2016 Oct; 25(4):135-45. PubMed ID: 27465822
[TBL] [Abstract][Full Text] [Related]
8. CREBBP mutations in individuals without Rubinstein-Taybi syndrome phenotype.
Menke LA; van Belzen MJ; Alders M; Cristofoli F; ; Ehmke N; Fergelot P; Foster A; Gerkes EH; Hoffer MJ; Horn D; Kant SG; Lacombe D; Leon E; Maas SM; Melis D; Muto V; Park SM; Peeters H; Peters DJ; Pfundt R; van Ravenswaaij-Arts CM; Tartaglia M; Hennekam RC
Am J Med Genet A; 2016 Oct; 170(10):2681-93. PubMed ID: 27311832
[TBL] [Abstract][Full Text] [Related]
9. Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism.
Oike Y; Hata A; Mamiya T; Kaname T; Noda Y; Suzuki M; Yasue H; Nabeshima T; Araki K; Yamamura K
Hum Mol Genet; 1999 Mar; 8(3):387-96. PubMed ID: 9949198
[TBL] [Abstract][Full Text] [Related]
10. Whole exome sequencing for a patient with Rubinstein-Taybi syndrome reveals de novo variants besides an overt CREBBP mutation.
Yoo HJ; Kim K; Kim IH; Rho SH; Park JE; Lee KY; Kim SA; Choi BY; Kim N
Int J Mol Sci; 2015 Mar; 16(3):5697-713. PubMed ID: 25768348
[TBL] [Abstract][Full Text] [Related]
11. The transcriptional coactivator and histone acetyltransferase CBP regulates neural precursor cell development and migration.
Schoof M; Launspach M; Holdhof D; Nguyen L; Engel V; Filser S; Peters F; Immenschuh J; Hellwig M; Niesen J; Mall V; Ertl-Wagner B; Hagel C; Spohn M; Lutz B; Sedlacik J; Indenbirken D; Merk DJ; Schüller U
Acta Neuropathol Commun; 2019 Dec; 7(1):199. PubMed ID: 31806049
[TBL] [Abstract][Full Text] [Related]
12. Case report: a Chinese girl like atypical Rubinstein-Taybi syndrome caused by a novel heterozygous mutation of the EP300 gene.
Bai Z; Li G; Kong X
BMC Med Genomics; 2023 Feb; 16(1):24. PubMed ID: 36797748
[TBL] [Abstract][Full Text] [Related]
13. Rubinstein-Taybi syndrome.
Kosaki R
Nihon Rinsho; 2017 Mar; 75(3):498-503. PubMed ID: 30566799
[TBL] [Abstract][Full Text] [Related]
14. Germline mosaicism in Rubinstein-Taybi syndrome.
Tajir M; Fergelot P; Lancelot G; Elalaoui SC; Arveiler B; Lacombe D; Sefiani A
Gene; 2013 Apr; 518(2):476-8. PubMed ID: 23352794
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic mechanisms of Rubinstein-Taybi syndrome.
Park E; Kim Y; Ryu H; Kowall NW; Lee J; Ryu H
Neuromolecular Med; 2014 Mar; 16(1):16-24. PubMed ID: 24381114
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel de novo mutation of CREBBP in a patient with Rubinstein-Taybi syndrome by targeted next-generation sequencing: a case report.
Kamenarova K; Simeonov E; Tzveova R; Dacheva D; Penkov M; Kremensky I; Perenovska P; Mitev V; Kaneva R
Hum Pathol; 2016 Jan; 47(1):144-9. PubMed ID: 26603346
[TBL] [Abstract][Full Text] [Related]
17. Rubinstein-Taybi syndrome: molecular findings and therapeutic approaches to improve cognitive dysfunction.
Hallam TM; Bourtchouladze R
Cell Mol Life Sci; 2006 Aug; 63(15):1725-35. PubMed ID: 16786226
[TBL] [Abstract][Full Text] [Related]
18. Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the clinical and genetic spectrum.
López M; García-Oguiza A; Armstrong J; García-Cobaleda I; García-Miñaur S; Santos-Simarro F; Seidel V; Domínguez-Garrido E
BMC Med Genet; 2018 Mar; 19(1):36. PubMed ID: 29506490
[TBL] [Abstract][Full Text] [Related]
19. Ablation of CBP in forebrain principal neurons causes modest memory and transcriptional defects and a dramatic reduction of histone acetylation but does not affect cell viability.
Valor LM; Pulopulos MM; Jimenez-Minchan M; Olivares R; Lutz B; Barco A
J Neurosci; 2011 Feb; 31(5):1652-63. PubMed ID: 21289174
[TBL] [Abstract][Full Text] [Related]
20. iPSC-derived neurons of CREBBP- and EP300-mutated Rubinstein-Taybi syndrome patients show morphological alterations and hypoexcitability.
Alari V; Russo S; Terragni B; Ajmone PF; Sironi A; Catusi I; Calzari L; Concolino D; Marotta R; Milani D; Giardino D; Mantegazza M; Gervasini C; Finelli P; Larizza L
Stem Cell Res; 2018 Jul; 30():130-140. PubMed ID: 29883886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
